APTORUM GROUP LIMITED Warrant To Purchase Class A Ordinary SharesWarrant Agreement • December 18th, 2018 • Aptorum Group LTD • Pharmaceutical preparations • New York
Aptorum Group Limited, a Cayman Islands company (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Boustead Securities, LLC, the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Class A Ordinary Shares with par value USD$1.00 each (including any Warrants to purchase shares issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the date on which the IPO (as defined herein below) is consummated and of the commencement of trading on a U.S. national securities exchange of the Company’s securities to be issued in such offering, to the extent permitted by the applicable SEC and FINRA rules, but not after 11:59 p.m., Eastern Time, on the Expiration Date (as defined be
UNDERWRITING AGREEMENTUnderwriting Agreement • December 18th, 2018 • Aptorum Group LTD • Pharmaceutical preparations • New York
Form of Lock-up AgreementLock-Up Agreement • December 18th, 2018 • Aptorum Group LTD • Pharmaceutical preparations • New York
The undersigned, a stockholder, director or officer of Aptorum Group Limited, a Cayman Islands company (the “Company”), understands that Boustead Securities, LLC (the “Representative”) will act as the representative of the underwriters, i.e., Boustead Securities, LLC, China Renaissance Securities (HK) Limited and AMTD Global Markets Limited (collectively, the “Underwriters”) to carry out an offering (the “Offering”) of the Company’s ordinary shares (the “Securities”). In recognition of the benefit that the Offering will confer upon the undersigned, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned agrees with the Underwriters that, without the prior written consent of the Underwriters, during a period of six (6) months 1 from the date on which the trading of the Securities on the NASDAQ Stock Exchange commences (the “Lock-Up Period”), the undersigned will not, without the prior written consent of the Representat
